viewNanoveu Ltd

Nanoveu shares soar as antiviral product sales accelerate across multiple geographies

Sales to Vietnam add to Nanoveu’s growing order book with customers in Australia, Malaysia, Singapore, Thailand, UK, and USA.

Nanoveu Ltd - Nanoveu shares soar as antiviral product sales accelerate across multiple geographies
The company’s antiviral protection product has proven effective for an increasing range of applications

Nanoveu Ltd (ASX:NVU) has soared after secured new sales for its B2B antiviral film and antiviral mobile phone protection product with a combined value in excess of A$250,000.

The accelerating sales activity, including a maiden shipment of antiviral film product to Vietnam, is being driven by Nanoveu’s recently appointed distribution partners and the increasingly broad number of applications for its products.

This growth also validates the effectiveness of Nanoveu's antiviral protection product for increasing applications.

Investors responded positively to the news with shares up as much as 55% to 8.9 cents intra-day.

“Expanding into new markets”

Nanoveu executive chairman and CEO Alfred Chong said: “Nanoveu is continuing to make strides to build up its order book and list of distributors.

“It is pleasing to see the various applications which the technology is being used for as well as the growing list of international partners.

“We are very excited to add another major destination such as Vietnam to our list of supplied countries and we now have sales in countries as diverse as the USA, Australia, UK and Singapore.

“Nanoveu will continue to keep shareholders updated as it expands into new markets.”

New distributors appointed

New distributors have recently been appointed including BrightEco Pte Ltd and Excelsia Technologies Sdn Bhd, HITEK Electronics Material Ltd, GNT Fine Wines Pty Ltd and Keywest Technology Ltd.

Proceeds from 53% of these sales have been received and the balance is due within the next 30 days under Nanoveu’s typical credit terms for large commercial customers.

Nanoveu-protected touchscreens have been installed on screens within one of Singapore’s largest shopping malls, Suntec Shopping Mall.

Antiviral screen protectors

A $70,000 sale through BrightEco will see the maiden shipment of Nanoveu product to Vietnam, with a focus on mobile phones.

This marks the first major sales order to focus on antiviral smartphone screen protectors.

Nanoveu is also pleased to have achieved deployment into one of the largest shopping malls in Singapore, Suntec City Mall, with more than 360 retail outlets over four storeys.

The Nanoveu film has been applied to 74 TV screen and touchscreen surfaces within the facility.

Luxury car market

An order has been received from an Asia-based vehicle accessory distributor, Excelsia Technologies Sdn Bhd, with the intent of applying the antiviral film in the touchscreens of luxury cars.

This marks the first application of the technology in vehicles and demonstrates the increasingly broad potential for antiviral protection.

Additional applications

Nanoveu’s antiviral technology has been independently demonstrated to be a highly effective agent for the eradication of viruses, proven to eliminate 99.99% of OC43, a viral strain affecting humans that is also a surrogate for COVID-19, in 30 minutes.

The antiviral protection has also been validated against other bacteria and viruses including e.Coli, Influenza A (subtype H3N2) and coronavirus MHV-A592 .

Discussions are ongoing for additional applications, including retrofitting self-check-in kiosks and security trays at airports and vending, automated distribution and gaming machine manufacturers have also shown a keen interest.

Pilot trials at hotel and restaurant chains are also underway.

Quick facts: Nanoveu Ltd

Price: 0.058 AUD

Market: ASX
Market Cap: $9.06 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Nanoveu Ltd named herein, including the promotion by the Company of Nanoveu Ltd in any Content on the Site, the Company receives from said...


Nanoveu focused on commercialising EyeFyx product following 'revolutionary'...

Nanoveu Ltd's (ASX:NVU) Alfred Chong caught up with Proactive's Andrew Scott after completing what they describe as a revolutionary advanced prototype of its EyeFyx product. It's designed to correct farsightedness for people using digital devices without the need for glasses. The company has...

on 18/11/20

3 min read